Single-nucleotide polymorphisms and DNA methylation markers associated with central obesity and regulation of body weight

Nutrition Reviews

Volumn 72, Issue 11, 2014, Pages 673-690

  Goni, Leticia ^a   Milagro, Fermín I ^a,b   Cuervo, Marta ^a,b   Martínez, J Alfredo ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

DNA methylation; Epigenomics; EWAS; Gene diet interaction; Genomics; GWAS; Obesity; Visceral fat

Indexed keywords

AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENOME; GENOMICS; HUMAN; INTRAABDOMINAL FAT; MEDLINE; META ANALYSIS (TOPIC); OBESITY; OUTCOME ASSESSMENT; PHENOTYPIC VARIATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION; ABDOMINAL OBESITY; FEMALE; GENETIC MARKER; GENETICS; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY;

GENETIC MARKER;

BODY WEIGHT; DNA METHYLATION; FEMALE; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; OBESITY, ABDOMINAL; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84908896632     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12143     Document Type: Article

References (162)

1. Abete I, Astrup A, Martinez JA, etal. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev. 2010;68:214-231.
2. Siddarth D. Risk factors for obesity in children and adults. J Investig Med. 2013;61:1039-1042.
3. Valassi E, Crespo I, Santos A, etal. Clinical consequences of Cushing's syndrome. Pituitary. 2012;15:319-329.
4. Moore CJ. Social position, psychological stress, and obesity: a systematic review. J Acad Nutr Diet. 2012;112:518-526.
5. Razquin C, Marti A, Martinez JA. Evidences on three relevant obesogenes: MC4R, FTO and PPARgamma. Approaches for personalized nutrition. Mol Nutr Food Res. 2011;55:136-149.
6. Hinnouho GM, Czernichow S, Dugravot A, etal. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care. 2013;36:2294-2300.
7. Thomas EL, Frost G, Taylor-Robinson SD, etal. Excess body fat in obese and normal-weight subjects. Nutr Res Rev. 2012;25:150-161.
8. Manios Y, Kanellakis S, Moschonis G, etal. Estimation of abdominal fat mass: validity of abdominal bioelectrical impedance analysis and a new model based on anthropometry compared with dual-energy x-ray absorptiometry. Menopause. 2013;20:1280-1283.
9. Shuster A, Patlas M, Pinthus JH, etal. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85:1-10.
10. Bush WS, Moore JH. Chapter 11: genome-wide association studies. PLoS Comput Biol. 2012;8:e1002822. doi: 10.1371/journal.pcbi.1002822.
11. Loos RJ. Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab. 2012;26:211-226.
12. McPherson JD, Marra M, Hillier L, etal. A physical map of the human genome. Nature. 2001;409:934-941.
13. International HapMap Consortium. The International HapMap project. Nature. 2003;426:789-796.
14. Day FR, Loos RJ. Developments in obesity genetics in the era of genome-wide association studies. J Nutrigenet Nutrigenomics. 2011;4:222-238.
15. Simopoulos AP. Nutrigenetics/nutrigenomics. Annu Rev Public Health. 2010;31:53-68.
16. San-Cristobal R, Milagro FI, Martinez JA. Future challenges and present ethical considerations in the use of personalized nutrition based on genetic advice. J Acad Nutr Diet. 2013;113:1447-1454.
17. Mansego ML, Milagro FI, Campion J, etal. Techniques of DNA methylation analysis with nutritional applications. J Nutrigenet Nutrigenomics. 2013;6:83-96.
18. Milagro FI, Mansego ML, De Miguel C, etal. Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives. Mol Aspects Med. 2013;34:782-812.
19. Ho JW, Bishop E, Karchenko PV, etal. ChIP-chip versus ChIP-seq: lessons for experimental design and data analysis. BMC Genomics 2011;12:134. doi: 10.1186/1471-2164-12-134.
20. Fazzari MJ, Greally JM. Introduction to epigenomics and epigenome-wide analysis. Methods Mol Biol. 2010;620:243-265.
21. Rakyan VK, Down TA, Balding DJ, etal. Epigenome-wide association studies for common human diseases. Nat Rev Genet. 2011;12:529-541.
22. Talens RP, Boomsma DI, Tobi EW, etal. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J. 2010;24:3135-3144.
23. Kristiansson K, Perola M, Tikkanen E, etal. Genome-wide screen for metabolic syndrome susceptibility loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet. 2012;5:242-249.
24. Wang K, Li WD, Zhang CK, etal. A genome-wide association study on obesity and obesity-related traits. PLoS One. 2011;6:e18939. doi: 10.1371/journal.pone.0018939.
25. Cho YS, Go MJ, Kim YJ, etal. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet. 2009;41:527-534.
26. Chambers JC, Elliott P, Zabaneh D, etal. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet. 2008;40:716-718.
27. Croteau-Chonka DC, Marvelle AF, Lange EM, etal. Genome-wide association study of anthropometric traits and evidence of interactions with age and study year in Filipino women. Obesity (Silver Spring). 2011;19:1019-1027.
28. Norris JM, Langefeld CD, Talbert ME, etal. Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: the IRAS Family Study. Obesity (Silver Spring). 2009;17:1932-1941.
29. Polasek O, Marusic A, Rotim K, etal. Genome-wide association study of anthropometric traits in Korcula Island, Croatia. Croat Med J. 2009;50:7-16.
30. Plourde M, Vohl MC, Bellis C, etal. A variant in the LRRFIP1 gene is associated with adiposity and inflammation. Obesity (Silver Spring). 2013;21:185-192.
31. Kilpeläinen TO, Qi L, Brage S, etal. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218, 166 adults and 19, 268 children. PLoS Med. 2011;8:e1001116. doi: 10.1371/journal.pmed.1001116.
32. Heid IM, Jackson AU, Randall JC, etal. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet. 2010;42:949-960.
33. Randall JC, Winkler TW, Kutalik Z, etal. Sex-stratified genome-wide association studies including 270, 000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 2013;9:e1003500. doi: 10.1371/journal.pgen.1003500.
34. Kraja AT, Vaidya D, Pankow JS, etal. A bivariate genome-wide approach to metabolic syndrome: STAMPEED Consortium. Diabetes. 2011;60:1329-1339.
35. Lindgren CM, Heid IM, Randall JC, etal. Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet. 2009;5:e1000508. doi: 10.1371/journal.pgen.1000508.
36. Berndt SI, Gustafsson S, Magi R, etal. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45:501-512.
37. Fox CS, Liu Y, White CC, etal. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS Genet. 2012;8:e1002695. doi: 10.1371/journal.pgen.1002695.
38. Liu CT, Monda KL, Taylor KC, etal. Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet. 2013;9:e1003681. doi: 10.1371/journal.pgen.1003681.
39. Heard-Costa NL, Zillikens MC, Monda KL, etal. NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet. 2009;5:e1000539. doi: 10.1371/journal.pgen.1000539.
40. Hindorff LA, MacArthur J, Morales J, et al. A Catalog of Published Genome-Wide Association Studies. Updated August 8, 2014. Bethesda, MD: National Human Genome Research Institute. Available at: http://www.genome.gov/gwastudies/. Accessed September 11, 2013.
41. Hoggart CJ, Clark TG, De Iorio M, etal. Genome-wide significance for dense SNP and resequencing data. Genet Epidemiol. 2008;32:179-185.
42. Panagiotou OA, Ioannidis JP, Genome-Wide Significance Project. What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. Int J Epidemiol. 2012;41:273-286.
43. Robitaille J, Despres JP, Perusse L, etal. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study. Clin Genet. 2003;63:109-116.
44. Robitaille J, Houde A, Lemieux S, etal. Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT1) gene interact with fat intake to modulate indices of obesity in French-Canadians. J Mol Med (Berl) 2007;85:129-137.
45. Song Y, Miyaki K, Araki J, etal. The interaction between the interleukin 6 receptor gene genotype and dietary energy intake on abdominal obesity in Japanese men. Metabolism. 2007;56:925-930.
46. Smith CE, Tucker KL, Yiannakouris N, etal. Perilipin polymorphism interacts with dietary carbohydrates to modulate anthropometric traits in Hispanics of Caribbean origin. J Nutr. 2008;138:1852-1858.
47. 3 polymorphisms and abdominal obesity in adults. J Nutr. 2009;139:2011-2017.
48. Phillips CM, Goumidi L, Bertrais S, etal. Additive effect of polymorphisms in the IL-6, LTA, and TNF-alpha genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. J Clin Endocrinol Metab. 2010;95:1386-1394.
49. Phillips CM, Goumidi L, Bertrais S, etal. ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat. J Lipid Res. 2010;51:3500-3507.
50. Dedoussis GV, Manios Y, Kourlaba G, etal. An age-dependent diet-modified effect of the PPARgamma Pro12Ala polymorphism in children. Metabolism. 2011;60:467-473.
51. Mattei J, Demissie S, Tucker KL, etal. The APOA1/C3/A4/A5 cluster and markers of allostatic load in the Boston Puerto Rican Health Study. Nutr Metab Cardiovasc Dis. 2011;21:862-870.
52. Phillips CM, Kesse-Guyot E, McManus R, etal. High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults. J Nutr. 2012;142:824-831.
53. Wang X, Zhu H, Snieder H, etal. Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Med. 2010;8:87. doi: 10.1186/1741-7015-8-87.
54. Feinberg AP, Irizarry RA, Fradin D, etal. Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med. 2010;2:49ra67. doi: 10.1126/scitranslmed.3001262.
55. Campión J, Milagro FI, Goyenechea E, etal. TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring). 2009;17:1293-1297.
56. Bouchard L, Rabasa-Lhoret R, Faraj M, etal. Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr. 2010;91:309-320.
57. Milagro FI, Campion J, Cordero P, etal. A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. FASEB J. 2011;25:1378-1389.
58. Cordero P, Campion J, Milagro FI, etal. Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J Physiol Biochem. 2011;67:463-470.
59. Milagro FI, Gomez-Abellan P, Campion J, etal. CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake. Chronobiol Int. 2012;29:1180-1194.
60. Moleres A, Campion J, Milagro FI, etal. Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study. FASEB J. 2013;27:2504-2512.
61. Fall T, Ingelsson E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol. 2012;382:740-757.
62. Santini F, Maffei M, Pelosini C, etal. Melanocortin-4 receptor mutations in obesity. Adv Clin Chem. 2009;48:95-109.
63. Xi B, Cheng H, Shen Y, etal. Study of 11 BMI-associated loci identified in GWAS for associations with central obesity in the Chinese children. PLoS One. 2013;8:e56472. doi: 10.1371/journal.pone.0056472.
64. Garzon J, Rodriguez-Munoz M, de la Torre-Madrid E, etal. Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS. Psychopharmacology (Berl). 2005;180:1-11.
65. Hishimoto A, Liu QR, Drgon T, etal. Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Hum Mol Genet. 2007;16:2880-2891.
66. Docampo E, Ribases M, Gratacos M, etal. Association of neurexin 3 polymorphisms with smoking behavior. Genes Brain Behav. 2012;11:704-711.
67. Berridge KC, Ho CY, Richard JM, etal. The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res. 2010;1350:43-64.
68. Manderfield LJ, Daniels MA, Vanoye CG, etal. KCNE4 domains required for inhibition of KCNQ1. J Physiol. 2009;587:303-314.
69. van Vliet-Ostaptchouk JV, van Haeften TW, Landman GW, etal. Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp. PLoS One. 2012;7:e32148. doi: 10.1371/journal.pone.0032148.
70. Smemo S, Tena JJ, Kim KH, etal. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature. 2014;507:371-375.
71. Speliotes EK, Willer CJ, Berndt SI, etal. Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937-948.
72. Scuteri A, Sanna S, Chen WM, etal. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3:e115. doi: 10.1371/journal.pgen.0030115.
73. Loos RJ, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev. 2008;9:246-250.
74. Liu C, Mou S, Pan C. The FTO gene rs9939609 polymorphism predicts risk of cardiovascular disease: a systematic review and meta-analysis. PLoS One. 2013;8:e71901. doi: 10.1371/journal.pone.007190.
75. Vasan SK, Karpe F, Gu HF, etal. FTO genetic variants and risk of obesity and type 2 diabetes: a meta-analysis of 28, 394 Indians. Obesity (Silver Spring) 2013;22:964-970.
76. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity. 2010;32:305-315.
77. Bille DS, Banasik K, Justesen JM, etal. Implications of central obesity-related variants in LYPLAL1, NRXN3, MSRA, and TFAP2B on quantitative metabolic traits in adult Danes. PLoS One. 2011;6:e20640. doi: 10.1371/journal.pone.0020640.
78. Maeda S, Tsukada S, Kanazawa A, etal. Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. J Hum Genet. 2005;50:283-292.
79. Nordquist N, Gokturk C, Comasco E, etal. The transcription factor TFAP2B is associated with insulin resistance and adiposity in healthy adolescents. Obesity (Silver Spring). 2009;17:1762-1767.
80. Kim HY, Gladyshev VN. Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem J. 2007;407:321-329.
81. Scherag A, Dina C, Hinney A, etal. Two new loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and German study groups. PLoS Genet. 2010;6:e1000916. doi: 10.1371/journal.pgen.1000916.
82. Steinberg GR, Kemp BE, Watt MJ. Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab. 2007;293:E958-E964.
83. Nishimura S, Manabe I, Nagasaki M, etal. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes. 2007;56:1517-1526.
84. Lijnen HR. Angiogenesis and obesity. Cardiovasc Res. 2008;78:286-293.
85. Schleinitz D, Kloting N, Lindgren CM, etal. Fat depot-specific mRNA expression of novel loci associated with waist-hip ratio. Int J Obes (Lond). 2014;38:120-125.
86. Gesta S, Bluher M, Yamamoto Y, etal. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A. 2006;103:6676-6681.
87. Graff M, Fernandez-Rhodes L, Liu S, etal. Generalization of adiposity genetic loci to US Hispanic women. Nutr Diabetes 2013;3:e85. doi: 10.1038/nutd.2013.26.
88. Hotta K, Kitamoto A, Kitamoto T, etal. Replication study of 15 recently published loci for body fat distribution in the Japanese population. J Atheroscler Thromb. 2013;20:336-350.
89. Zheng XY, Zhao SP, Yan H. The role of apolipoprotein A5 in obesity and the metabolic syndrome. Biol Rev Camb Philos Soc. 2013;88:490-498.
90. Huggins GS, Papandonatos GD, Erar B, etal. Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: the Action for Health in Diabetes (Look AHEAD) study. Circ Cardiovasc Genet. 2013;6:391-399.
91. Agirbasli M, Eren F, Agirbasli D, etal. Multi-locus candidate gene analyses of lipid levels in a pediatric Turkish cohort: lessons learned on LPL, CETP, LIPC, ABCA1, and SHBG. OMICS. 2013;17:636-645.
92. Ling Y, Li X, Gu Q, etal. Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study. BMC Med Genet. 2011;12:66. doi: 10.1186/1471-2350-12-66.
93. Varbo A, Benn M, Tybjaerg-Hansen A, etal. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population. Arterioscler Thromb Vasc Biol. 2011;31:451-457.
94. Ramasamy I. Recent advances in physiological lipoprotein metabolism. Clin Chem Lab Med. 2013;12:1-33.
95. Neale BM, Fagerness J, Reynolds R, etal. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A. 2010;107:7395-7400.
96. Carroll EA, Gerrelli D, Gasca S, etal. Cordon-bleu is a conserved gene involved in neural tube formation. Dev Biol. 2003;262:16-31.
97. Manning AK, Hivert MF, Scott RA, etal. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012;44:659-669.
98. Mancina RM, Burza MA, Maglio C, etal. The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children. Diabetes Metab Res Rev. 2013;29:413-416.
99. Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2010;1802:396-405.
100. Waterworth DM, Ricketts SL, Song K, etal. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2010;30:2264-2276.
101. Mehtala ML, Lensink MF, Pietikainen LP, etal. On the molecular basis of d-bifunctional protein deficiency type III. PLoS One. 2013;8:e53688.
102. Galbete C, Toledo E, Martinez-Gonzalez MA, etal. Pro12Ala variant of the PPARG2 gene increases body mass index: an updated meta-analysis encompassing 49, 092 subjects. Obesity (Silver Spring). 2013;21:1486-1495.
103. Dahl L, Richter K, Hagglund AC, etal. Lhx2 expression promotes self-renewal of a distinct multipotential hematopoietic progenitor cell in embryonic stem cell-derived embryoid bodies. PLoS One. 2008;3:e2025. doi: 10.1371/journal.pone.0002025.
104. Marti A, Goyenechea E, Martinez JA. Nutrigenetics: a tool to provide personalized nutritional therapy to the obese. J Nutrigenet Nutrigenomics. 2010;3:157-169.
105. Abeywardena MY, Leifert WR, Warnes KE, etal. Cardiovascular biology of interleukin-6. Curr Pharm Des. 2009;15:1809-1821.
106. Hsieh CH, Hung YJ, Wu LI, etal. Interleukin-6 receptor gene 48892 A/C polymorphism is associated with metabolic syndrome in female Taiwanese adolescents. Genet Test Mol Biomarkers 2012;16:1376-1381.
107. Bondurant KL, Lundgreen A, Herrick JS, etal. Interleukin genes and associations with colon and rectal cancer risk and overall survival. Int J Cancer. 2013;132:905-915.
108. Bonnefont JP, Djouadi F, Prip-Buus C, etal. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med. 2004;25:495-520.
109. Zhang SS, Liu MG, Kano A, etal. STAT3 activation in response to growth factors or cytokines participates in retina precursor proliferation. Exp Eye Res. 2005;81:103-115.
110. Wunderlich CM, Hovelmeyer N, Wunderlich FT. Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAKSTAT. 2013;2:e23878. doi: 10.4161/jkst.23878.
111. Tzanavari T, Giannogonas P, Karalis KP. TNF-alpha and obesity. Curr Dir Autoimmun. 2010;11:145-156.
112. Upadhyay V, Fu YX. Lymphotoxin signalling in immune homeostasis and the control of microorganisms. Nat Rev Immunol. 2013;13:270-279.
113. Mahajan A, Tabassum R, Chavali S, etal. Obesity-dependent association of TNF-LTA locus with type 2 diabetes in North Indians. J Mol Med (Berl). 2010;88:515-522.
114. Wakil SJ, Abu-Elheiga LA. Fatty acid metabolism: target for metabolic syndrome. J Lipid Res. 2009;50(Suppl):S138-S143.
115. Riancho JA, Vazquez L, Garcia-Perez MA, etal. Association of ACACB polymorphisms with obesity and diabetes. Mol Genet Metab. 2011;104:670-676.
116. Glund S, Schoelch C, Thomas L, etal. Inhibition of acetyl-CoA carboxylase 2 enhances skeletal muscle fatty acid oxidation and improves whole-body glucose homeostasis in db/db mice. Diabetologia. 2012;55:2044-2053.
117. Zhong L, Li Q, Jiang Y, etal. The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population. Inflammation. 2010;33:353-358.
118. Hsu MC, Chang CS, Lee KT, etal. Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster. Nutr Diabetes 2013;3:e61. doi: 10.1038/nutd.2013.2.
119. Yu D, Li C, Xie J, etal. Association between three genetic variants of the perilipin gene (PLIN) and glucose metabolism: results from a replication study among Chinese adults and a meta-analysis. Endocr Res. 2013;38:263-279.
120. Smith CE, Ordovas JM. Update on perilipin polymorphisms and obesity. Nutr Rev. 2012;70:611-621.
121. Corella D, Qi L, Tai ES, etal. Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet. Diabetes Care. 2006;29:1313-1319.
122. Hainer V, Zamrazilová H, Spálová J, etal. Role of hereditary factors in weight loss and its maintenance. Physiol Res. 2008;57(Suppl):S1-S15.
123. Hermsdorff HH, Mansego ML, Campion J, etal. TNF-alpha promoter methylation in peripheral white blood cells: relationship with circulating TNFalpha, truncal fat and n-6 PUFA intake in young women. Cytokine. 2013;64:265-271.
124. Shiokawa D, Matsushita T, Kobayashi T, etal. Characterization of the human DNAS1L2 gene and the molecular mechanism for its transcriptional activation induced by inflammatory cytokines. Genomics. 2004;84:95-105.
125. Renner AB, Walter A, Fiebig BS, etal. Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation. Doc Ophthalmol. 2012;125:81-89.
126. Dhar M, Hauser L, Johnson D. An aminophospholipid translocase associated with body fat and type 2 diabetes phenotypes. Obes Res. 2002;10:695-702.
127. DuBose AJ, Johnstone KA, Smith EY, etal. Atp10a, a gene adjacent to the PWS/AS gene cluster, is not imprinted in mouse and is insensitive to the PWS-IC. Neurogenetics. 2010;11:145-151.
128. Kang HS, Liao G, DeGraff LM, etal. CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance. PLoS One. 2013;8:e58417. doi: 10.1371/journal.pone.0058417.
129. Li X, Wang S, Sitaram RT, etal. Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma. PLoS One. 2013;8:e58396. doi: 10.1371/journal.pone.0058396.
130. Fischbach BV, Trout KL, Lewis J, etal. WAGR syndrome: a clinical review of 54 cases. Pediatrics. 2005;116:984-988.
131. Steege A, Fahling M, Paliege A, etal. Wilms' tumor protein (-KTS) modulates renin gene transcription. Kidney Int. 2008;74:458-466.
132. Milagro FI, Campion J, Garcia-Diaz DF, etal. High fat diet-induced obesity modifies the methylation pattern of leptin promoter in rats. J Physiol Biochem. 2009;65:1-9.
133. Gomez-Abellan P, Madrid JA, Ordovas JM, etal. Chronobiological aspects of obesity and metabolic syndrome. Endocrinol Nutr. 2012;59:50-61.
134. Maeda N. Implications of aquaglyceroporins 7 and 9 in glycerol metabolism and metabolic syndrome. Mol Aspects Med. 2012;33:665-675.
135. Maeda N, Funahashi T, Shimomura I. Cardiovascular-metabolic impact of adiponectin and aquaporin. Endocr J. 2013;60:251-259.
136. Sekine Y, Tsuji S, Ikeda O, etal. Regulation of STAT3-mediated signaling by LMW-DSP2. Oncogene. 2006;25:5801-5806.
137. Nayak SB, Pinto Pereira LM, Boodoo S, etal. Association of troponin T and altered lipid profile in patients admitted with acute myocardial infarction. Arch Physiol Biochem. 2010;116:21-27.
138. Guay SP, Voisin G, Brisson D, etal. Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration. Epigenomics. 2012;4:623-639.
139. Crujeiras AB, Campion J, Diaz-Lagares A, etal. Association of weight regain with specific methylation levels in the NPY and POMC promoters in leukocytes of obese men: a translational study. Regul Pept. 2013;186:1-6.
140. Beckers S, Zegers D, Van Gaal LF, etal. The role of the leptin-melanocortin signalling pathway in the control of food intake. Crit Rev Eukaryot Gene Expr. 2009;19:267-287.
141. Zhang L, Bijker MS, Herzog H. The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer. Pharmacol Ther. 2011;131:91-113.
142. Jacobsen SC, Brons C, Bork-Jensen J, etal. Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men. Diabetologia. 2012;55:3341-3349.
143. Godfrey KM, Sheppard A, Gluckman PD, etal. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes. 2011;60:1528-1534.
144. Dolle P. Developmental expression of retinoic acid receptors (RARs). Nucl Recept Signal. 2009;7:e006. doi: 10.1621/nrs.07006.
145. Lima LO, Almeida S, Hutz MH, etal. PPARA, RXRA, NR1/2 and NR1/3 gene polymorphisms and lipid and lipoprotein levels in a Southern Brazilian population. Mol Biol Rep. 2013;40:1241-1247.
146. Relton CL, Groom A, St Pourcain B, etal. DNA methylation patterns in cord blood DNA and body size in childhood. PLoS One. 2012;7:e31821. doi: 10.1371/journal.pone.0031821.
147. Mariman EC, Wang P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci. 2010;67:1277-1292.
148. Qiu J, Ni YH, Gong HX, etal. Identification of differentially expressed genes in omental adipose tissues of obese patients by suppression subtractive hybridization. Biochem Biophys Res Commun. 2007;352:469-478.
149. Duffy SL, Coulthard MG, Spanevello MD, etal. Generation and characterization of EphA1 receptor tyrosine kinase reporter knockout mice. Genesis. 2008;46:553-561.
150. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell. 2008;133:38-52.
151. Perkins E, Murphy SK, Murtha AP, etal. Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children. J Pediatr. 2012;161:31-39.
152. Renfree MB, Suzuki S, Kaneko-Ishino T. The origin and evolution of genomic imprinting and viviparity in mammals. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120151. doi: 10.1098/rstb.2012.0151.
153. Edwards CA, Ferguson-Smith AC. Mechanisms regulating imprinted genes in clusters. Curr Opin Cell Biol. 2007;19:281-289.
154. Huang RC, Galati JC, Burrows S, etal. DNA methylation of the IGF2/H19 imprinting control region and adiposity distribution in young adults. Clin Epigenetics 2012;4:21. doi: 10.1186/1868-7083-4-21.
155. Perng W, Mora-Plazas M, Marin C, etal. A prospective study of LINE-1 DNA methylation and development of adiposity in school-age children. PLoS One. 2013;8:e62587. doi: 10.1371/journal.pone.0062587.
156. Zhu ZZ, Hou L, Bollati V, etal. Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol. 2012;41:126-139.
157. Murata A, Baba Y, Watanabe M, etal. Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer. Br J Cancer. 2013;109:408-415.
158. Cash HL, McGarvey ST, Houseman EA, etal. Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders. Epigenetics. 2011;6:1257-1264.
159. Pearce MS, McConnell JC, Potter C, etal. Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles. Int J Epidemiol. 2012;41:210-217.
160. Vasan SK, Fall T, Job V, etal. A common variant in the FTO locus is associated with waist-hip ratio in Indian adolescents. Pediatr Obes. 2013;8:e45-e49.
161. Lim U, Ernst T, Wilkens LR, etal. Susceptibility variants for waist size in relation to abdominal, visceral, and hepatic adiposity in postmenopausal women. J Acad Nutr Diet. 2012;112:1048-1055.
162. Martinez JA, Milagro FI, Claycombe KJ, etal. Epigenetics in adipose tissue, obesity, weight loss and diabetes. Adv Nutr. 2014;5:71-81.